Nalaganje...
The MitoNEET Ligand NL-1 Mediates Antileukemic Activity in Drug-Resistant B-Cell Acute Lymphoblastic Leukemia
Disease relapse in B-cell acute lymphoblastic leukemia (ALL), either due to development of acquired resistance after therapy or because of de novo resistance, remains a therapeutic challenge. In the present study, we have developed a cytarabine (Ara-C)-resistant REH cell line (REH/Ara-C) as a chemor...
Shranjeno v:
| izdano v: | J Pharmacol Exp Ther |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
The American Society for Pharmacology and Experimental Therapeutics
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6538890/ https://ncbi.nlm.nih.gov/pubmed/31010844 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/jpet.118.255984 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|